These results reveal a previously uncharacterized mechanism by which cDCS regulates ischemia-induced pathological synaptic plasticity via modulation of NMDAR and FKBP51, highlighting its potential as a non-invasive neuromodulatory strategy for targeting ischemia-induced excitotoxicity. Here, FKBP5 is linked to ischemia.